The battle against lung cancer gained a potential boost in late May with the introduction of bipartisan federal legislation to study the disease’s impact on female patients.
, the Women and Lung Cancer Research and Preventive Services Act of 2016, would mandate that the Department of Health and Human Services (HHS) lead an interagency analysis to evaluate the status of and make recommendations for increased research on women and lung cancer, lung cancer preventive services, access, and strategic lung cancer public awareness and education campaigns.
In particular, the interagency study must identify existing gaps in lung cancer research, evaluate environmental and genomic factors that may contribute to the origins of lung cancer as well as foster advances in imaging technology that are expected to improve risk assessment, diagnosis and treatment and simultaneously aid lung cancer preventive services. HHS would be required to deliver the completed report to Congress 180 days following the date of the legislation’s enactment.
Key members of the House and Senate Lung Cancer Caucus are serving as lead sponsors of the legislation. H.R. 5253 was introduced by Reps. Rick Nolan (D-MN), Frank LoBiondo (R-NJ), Lois Capps (D-CA) and Peter DeFazio (D-OR). Sens. Kelly Ayotte (R-NH), Marco Rubio (R-FL) Dianne Feinstein (D-CA) and Maria Cantwell (D-WA) are the anchors of the Senate bill.
The American College of Radiology (ACR) supports HR. 5263/S. 2941 and its emphasis on researching ways to combat the incidence of lung cancer among women. The ACR looks forward to working with the key bill sponsors to enact this important legislation.